Harbor Capital Cuts Alibaba, Salesforce

Firm's largest sales of the 3rd quarter

Author's Avatar
Oct 01, 2020
Article's Main Image

Spiros Segalas (Trades, Portfolio)' Harbor Capital Appreciation Fund manages a $37.35 billion equity portfolio composed of 54 stocks. The firm sold shares of the following stocks during its third quarter of fiscal 2020, which ended on July 31.

Alibaba

The firm reduced its position in Alibaba Group Holding Ltd. (BABA) by 35.85%. The trade had an impact of -1.18% on the portfolio.

c8f0d230c0c45775c900d5223c96c367.png

The chinese online and mobile commerce company has a market cap of $795.40 billion and an enterprise value of $774.34 billion.

GuruFocus gives the company a profitability and growth rating of 9 out of 10. The return on equity of 25.43% and return on assets of 14.11% are outperforming 92% of companies in the retail, cyclical industry. Its financial strength is rated 8 out of 10. The cash-debt ratio of 3.08 is above the industry median of 0.46.

The largest guru shareholder of the stock is Ken Fisher (Trades, Portfolio) with 0.50% of outstanding shares, followed by PRIMECAP Management (Trades, Portfolio) with 0.49% and Frank Sands (Trades, Portfolio) with 0.26%.

Salesforce.com

The firm's Salesforce.com Inc. (CRM) position was reduced by 27.96%. The portfolio was impacted by -1.08%.

438390542037bb2a08acee0f37d1e8f5.png

The company, which offers enterprise cloud computing solutions, has a market cap of $228.70 billion and an enterprise value of $225.27 billion.

GuruFocus gives the company a profitability and growth rating of 5 out of 10. The return on equity of 7.52% and return on assets of 4.74% are outperforming 57% of companies in the software industry. Its financial strength is rated 7 out of 10. The cash-debt ratio of 1.59 is above the industry median of 2.14.

The largest guru shareholder is Fisher with 1.28% of outstanding shares, followed by Segalas with 0.57% and Pioneer Investments (Trades, Portfolio) with 0.44%.

Eli Lilly

The guru's firm curbed its position in Eli Lilly and Co. (LLY) by 45.7%. The portfolio was impacted by -1.05%.

a87376861192fe4218d6eb09ea32387e.png

The drug company has a market cap of $141.58 billion and an enterprise value of $155.70 billion.

GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on equity of 176.21% and return on assets of 14.12% are outperforming 91% of companies in the drug manufacturers industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.15 is below the industry median of 0.84.

The largest guru shareholder is PRIMECAP Management (Trades, Portfolio) with 4.14% of outstanding shares, followed by Vanguard Health Care Fund (Trades, Portfolio) with 0.10%.

Boeing

The firm closed its Boeing Co. (BA) holding, impacting the portfolio by -0.94%.

790d907c75ed22909e21689bfd5a3a83.png

The aerospace and defense firm has a market cap of $93.28 billion and an enterprise value of $122.51 billion.

GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on assets of 2.04%% is underperforming 66% of companies in the aerospace and defense industry. Its financial strength is rated 3 out of 10. The cash-debt ratio of 0.53 is below the industry median of 0.57.

The largest guru shareholder is Philippe Laffont (Trades, Portfolio) with 0.49% of outstanding shares, followed by T Rowe Price Equity Income Fund (Trades, Portfolio) with 0.21% and Pioneer Investments (Trades, Portfolio) with 0.07%.

NVIDIA

The investment firm curbed its holding of NVIDIA Corp. (NVDA) by 26.05%. The portfolio was impacted by -0.93%.

ed819e0068a012e6215b9ee65f21b096.png

The company, which designs graphics processing units, has a market cap of $334.32 billion and an enterprise value of $331.03 billion.

GuruFocus gives the company a profitability and growth rating of 10 out of 10. The return on equity of 27.89% and return on assets of 17.59% are outperforming 94% of companies in the semiconductors industry. Its financial strength is rated 7 out of 10 with the cash-debt ratio of 1.43.

The largest guru shareholder is Segalas with 0.44% of outstanding shares, followed by PRIMECAP Management (Trades, Portfolio) with 0.44% and Pioneer Investments (Trades, Portfolio) with 0.29%.

Boston Scientific

The investment firm exited its Boston Scientific Corp. (BSX) position. The trade had an impact of -0.80% on the portfolio.

eb4dd236e864bf0a8fed0a193b00600a.png

The company, which provides less-invasive medical devices, has a market cap of $54.67 billion and an enterprise value of $62.74 billion.

GuruFocus gives the company a profitability and growth rating of 6 out of 10. The return on equity of 31.88% and return on assets of 13.98% are outperforming 90% of companies in the medical devices and instruments industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.18 is below the industry median of 1.74.

The largest guru shareholder of the company is PRIMECAP Management (Trades, Portfolio) with 2.91% of outstanding shares, followed by Vanguard Health Care Fund (Trades, Portfolio) with 2.57% and Andreas Halvorsen (Trades, Portfolio) with 1.29%.

Microsoft

Segalas' firm reduced its holding of Microsoft Corp. (MSFT) by 11.54%. The portfolio was impacted by -0.78%.

4da107e0976549d5ed1b257ee751008d.png

The hardware and software producer has a market cap of $1.59 trillion and an enterprise value of $1.53 trillion.

GuruFocus gives the company a profitability and growth rating of 9 out of 10. The return on equity of 40.16% and return on assets of 15.43% are outperforming 92% of companies in the software industry. Its financial strength is rated 7 out of 10. The cash-debt ratio of 1.92 is below the industry median of 2.2.

The largest guru shareholder of the company is PRIMECAP Management (Trades, Portfolio) with 0.32% of outstanding shares, followed by Fisher with 0.29%, Pioneer Investments (Trades, Portfolio) with 0.27% and Dodge & Cox with 0.26%.

Disclosure: I do not own any stocks mentioned.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.